NXNuli Xie

Nuli Xie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nuli Xie has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Kemin Wang

    Hunan University

    20 shared publications
  • Ke Quan

    State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province , Hunan University , Changsha 410082 , P.R. China

    16 shared publications
  • Yanjing Yang

    State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province , Hunan University , Changsha 410082 , P.R. China

    16 shared publications
  • Jin Huang

    State Key Laboratory of Chemo and Biosensing, Hunan University

    15 shared publications
  • Min Ou

    State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province , Hunan University , Changsha 410082 , China

    13 shared publications
  • Xiaohai Yang

    State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha, China

    13 shared publications

Latest Publications

  • Precise Disease Analysis and Diagnosis Driven by DNA Circuits: From Single Target to Multiple Targets, From Simple to Intelligent

    by Sujing Li, Sisi Wang, Yanbin Li, Yinting Huang, Qubo Zhu, Lin Mei, Wenhu Zhou, Nuli Xie

    Medical decision‐making and treatment efficacy depend fundamentally on accurate and early diagnosis. However, conventional diagnostic paradigms often face hurdles related to high invasiveness and a lack of molecular‐level accuracy. To overcome these limitations, DNA circuits have flourished as a transformative technology, leveraging programmable dynamic DNA reaction networks to propel the field toward a new frontier of real‐time intelligence and high‐precision disease theranostics. In this review, we summarized the evolution of DNA circuits in disease diagnosis, with a focus on how they are becoming increasingly accurate, efficient, and intelligent. First, focusing on the input layer of DNA circuits, the evolution of detection targets from single target to multiple targets and multi‐dimensional biomarkers was reviewed. Second, focusing on the core architecture of DNA circuits, we analyzed the architectural transition from simple logic gates to scalable and modular circuits that integrate algorithmic logic for intelligent diagnosis, signal amplification for low‐abundance targets, and optimize circuit stability. Additionally, we surveyed recent developments in DNA circuits in disease diagnosis, analysis, and treatment. Finally, we discussed the remaining limitations and offer perspectives on the future of intelligent DNA circuits.

  • Open Access

    Targeted DNA Nanomachine Enables Specific miRNA‐Responsive Singlet Oxygen Amplification for Precise Cutaneous Squamous Cancer Therapy

    by Hanane Aliouat, Detian Zhang, Lanyuan Peng, Jiaxin Huang, Hongshi Cheng, Jiaojiao Zhu, Xiang Chen, Nuli Xie, Wenhu Zhou, Shuang Zhao

    Photodynamic therapy (PDT) is a promising strategy for the treatment of skin‐related tumors including cutaneous squamous cells carcinoma (cSCC). However, it is hard to balance the dosage off‐target phototoxicity while maintaining satisfactory therapeutic effect. In addition, oxygen‐dependent photosensitizers (PSs) are affected by tumor hypoxic environment, which further causes inefficient photocatalysis and reduces therapeutic effect. Herein, an intelligent DNA nanomachine based on tetrahedral DNA framework is proposed, incorporated with tumor‐targeted aptamer and specific miRNA‐responsive hairpin DNA catalytic assembly (HCA), for precise and high‐efficient therapy of cSCC. After aptamer‐mediated targeted delivery, a cSCC‐specific miRNA selected by tissue sequencing analysis is used to activateHCA, for amplifying PSs and controllably releasing chemotherapeutic drugs. Sequential recognition can greatly improve tumor‐specific accumulation and high‐dose activation. Moreover, hemin is incorporated into DNA to catalytically produce oxygen. In vitro and in vivo experiments demonstrated that this DNA nanomachine greatly improved anti‐tumor effect and realized effective ablation of cSCC in mice, with barely systemic toxicity and inflammation. It is anticipated that this strategy will promote biomedical applications of tumor‐specific miRNA and provide a promising option for the non‐invasive treatment of skin‐associated tumors.


  • Copper Coordination‐Based Nanomedicine for Tumor Theranostics

    by Yuanfeng Han, Nuli Xie, Wenhu Zhou

    Copper (Cu) is an essential micronutrient for a variety of basic biological processes, including cell metabolism, proliferation, and angiogenesis. Recently, the concept of cuproptosis has been found to be related to the direct binding of Cu to the lipoylated components of the tricarboxylic acid cycle. This further demonstrates the important role of Cu and promotes Cu‐involved biomedical research. Currently, Cu‐related nanomedicines is mainly based on Cu coordination chemistry, and targeting Cu become a research hotspot for cancer therapy. On one hand, chelating excess Cu in vivo to inhibit angiogenesis, on the other hand, supplementing Cu and Cu‐coordinated complexes to produce oxidative stress and proteasome inhibition. In this review, the principles of Cu‐coordination chemistry and the biochemical functions of Cu ions are described, and a comprehensive review of Cu‐coordinated nanomedicine, including Cu chelation and Cu supplementation, delivery of Cu‐coordinated nanodrugs, and Cu‐coordinated nanocarriers is provided. Finally, the limitations are analyzed to point out the directions for improvement in future research. It is believed that the development of Cu‐coordinated nanomedicine will enter the fast track and show great promise in cancer theranostics.


  • Top Cited Papers

    DNA-based programmable gate arrays for general-purpose DNA computing

    by Hui Lv, Nuli Xie, Mingqiang Li, Mingkai Dong, Chenyun Sun, Qian Zhang, Lei Zhao, Jiang Li, Xiaolei Zuo, Haibo Chen, et al.

    The past decades have witnessed the evolution of electronic and photonic integrated circuits, from application specific to programmable1,2. Although liquid-phase DNA circuitry holds the potential for massive parallelism in the encoding and execution of algorithms3,4, the development of general-purpose DNA integrated circuits (DICs) has yet to be explored. Here we demonstrate a DIC system by integration of multilayer DNA-based programmable gate arrays (DPGAs). We find that the use of generic single-stranded oligonucleotides as a uniform transmission signal can reliably integrate large-scale DICs with minimal leakage and high fidelity for general-purpose computing. Reconfiguration of a single DPGA with 24 addressable dual-rail gates can be programmed with wiring instructions to implement over 100 billion distinct circuits. Furthermore, to control the intrinsically random collision of molecules, we designed DNA origami registers to provide the directionality for asynchronous execution of cascaded DPGAs. We exemplify this by a quadratic equation-solving DIC assembled with three layers of cascade DPGAs comprising 30 logic gates with around 500 DNA strands. We further show that integration of a DPGA with an analog-to-digital converter can classify disease-related microRNAs. The ability to integrate large-scale DPGA networks without apparent signal attenuation marks a key step towards general-purpose DNA computing.


  • Open Access

    Bacterial Drug Delivery Systems for Cancer Therapy: “Why” and “How”

    by Xiangcheng Zhao, Nuli Xie, Hailong Zhang, Wenhu Zhou, Jinsong Ding

    Cancer is one of the major diseases that endanger human health. However, the use of anticancer drugs is accompanied by a series of side effects. Suitable drug delivery systems can reduce the toxic side effects of drugs and enhance the bioavailability of drugs, among which targeted drug delivery systems are the main development direction of anticancer drug delivery systems. Bacteria is a novel drug delivery system that has shown great potential in cancer therapy because of its tumor-targeting, oncolytic, and immunomodulatory properties. In this review, we systematically describe the reasons why bacteria are suitable carriers of anticancer drugs and the mechanisms by which these advantages arise. Secondly, we outline strategies on how to load drugs onto bacterial carriers. These drug-loading strategies include surface modification and internal modification of bacteria. We focus on the drug-loading strategy because appropriate strategies play a key role in ensuring the stability of the delivery system and improving drug efficacy. Lastly, we also describe the current state of bacterial clinical trials and discuss current challenges. This review summarizes the advantages and various drug-loading strategies of bacteria for cancer therapy and will contribute to the development of bacterial drug delivery systems.


  • Three-Dimensional Molecular Transfer from DNA Nanocages to Inner Gold Nanoparticle Surfaces

    by Nuli Xie, Shiyuan Liu, Hongmei Fang, Yanjing Yang, Ke Quan, Jing Li, Xiaohai Yang, Kemin Wang, Jin Huang

    It is of great interest to construct DNA-functionalized gold nanoparticles (DNA-AuNPs) with a controllable number of DNA strands and relative orientations. Herein, we describe a three-dimensional (3D) molecular transfer strategy, in which a pattern of DNA strands can be transferred from a DNA icosahedron cage (I-Cage) to the wrapped AuNP surface. The results show that DNA-AuNPs produced by this method inherit DNA pattern information encoded in the transient I-Cage template with high fidelity. Controllable numbers and positions of DNA on the surface of AuNPs can be simultaneously realized by direct “printing” of a DNA pattern from the nanoshell (I-Cage) to the nanocore (AuNP), further expanding the applications of DNA nanotechnology to nanolithography. Prospectively, the customized DNA-printed nanoparticles (DPNPs) possess great potential for constructing programmable architectures for optoelectronic devices as well as smart biosensors for biomedical applications.


  • Open Access

    Dual-microRNA-controlled double-amplified cascaded logic DNA circuits for accurate discrimination of cell subtypes

    by Ke Quan, Jing Li, Jiaoli Wang, Nuli Xie, Qiaomei Wei, Jinlu Tang, Xiaohai Yang, Kemin Wang, Jin Huang

    We have designed dual-microRNA-controlled cascaded logic DNA circuits for cancer cell subtype identification. The basic idea is to improve sensitivity by cascading DNAzyme and hybridization chain reaction (HCR), and improve accuracy by simultaneous detection of miR-122 and miR-21.


  • Gold nanoparticle-based 2′-O-methyl modified DNA probes for breast cancerous theranostics

    by Jing Li, Jin Huang, Xiaohai Yang, Yanjing Yang, Ke Quan, Nuli Xie, Yanan Wu, Changbei Ma, Kemin Wang


  • Detection of Nucleic Acids in Complex Samples via Magnetic Microbead-Assisted Catalyzed Hairpin Assembly and “DD–A” FRET

    by Hongmei Fang, Nuli Xie, Min Ou, Jin Huang, Wenshan Li, Qing Wang, Jianbo Liu, Xiaohai Yang, Kemin Wang

    Nucleic acids, as one kind of significant biomarkers, have attracted tremendous attention and exhibited immense value in fundamental studies and clinical applications. In this work, we developed a fluorescent assay for detecting nucleic acids in complex samples based on magnetic microbead (MMB)-assisted catalyzed hairpin assembly (CHA) and donor donor–acceptor fluorescence resonance energy transfer (“DD-A” FRET) signaling mechanism. Three types of DNA hairpin probes were employed in this system, including Capture, H1 (double FAM-labelled probe as FRET donor) and H2 (TAMRA-labelled probe as FRET acceptor). Firstly, the Captures immobilized on MMBs bound to targets in complex samples, and the sequences in Captures that could trigger catalyzed hairpin assembly (CHA) were exposed. Then, target-enriched MMBs complexes were separated and resuspended in the reaction buffer containing H1 and H2. As a result, numerous H1-H2 duplexes were formed during CHA process, inducing an obvious FRET signal. In contrast, CHA could not be trigger and the FRET signal was weak while target was absent. With the aid of magnetic separation and “DD-A” FRET, it was demonstrated to effectively eliminate errors from background interference. Importantly, this strategy realized amplified detection in buffer, with detection limits of microRNA as low as 34 pM. Furthermore, this method was successfully applied to detect microRNA-21 in serum and cell culture media. The results showed that our method has the potential for biomedical research and clinical application.


  • Live‐Cell MicroRNA Imaging through MnO2 Nanosheet‐Mediated DD‐A Hybridization Chain Reaction

    by Min Ou, Jin Huang, Xiaohai Yang, Xiaoxiao He, Ke Quan, Yanjing Yang, Nuli Xie, Jing Li, Kemin Wang

    Innovative techniques to visualize native microRNAs (miRNAs) in live cells can dramatically impact current research on the roles of miRNA in biology and medicine. Here, we report a novel approach for live‐cell miRNA imaging using a biodegradable MnO2 nanosheet‐mediated DD‐A FRET hybridization chain reaction (HCR). The MnO2 nanosheets can adsorb DNA hairpin probes and deliver them into live cells. After entering cells, the MnO2 nanosheets are degraded by cellular GSH. Then, the target miR‐21 triggers cascaded assembly of the liberated hairpin probes into long dsDNA polymers, which brings each two FAMs (donor) and one TAMRA (acceptor) into close proximity to generate significantly enhanced DD‐A FRET signals, which was discovered and proven by our previous report. We think the developed approach can serve as an excellent intracellular miRNAs detection tool, which promises the potential for biological and disease studies.